CRIPTO3 and metabolic dysfunction-associated steatotic liver disease: CR3 is expressed in the liver (111), and the activation level of the complement system is related to NAFLD severity (112), suggesting the involvement of P. gingivalis fimbriae in the pathogenesis of NAFLD via immune response induction.